Intrua Financial LLC Has $1.06 Million Holdings in UnitedHealth Group Incorporated $UNH

Intrua Financial LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 21.7% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 2,017 shares of the healthcare conglomerate’s stock after selling 559 shares during the quarter. Intrua Financial LLC’s holdings in UnitedHealth Group were worth $1,056,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd lifted its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $42,000. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $42,000. Finally, Investment Management Corp VA ADV bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $44,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.2%

Shares of UNH opened at $347.27 on Thursday. The firm has a market cap of $314.51 billion, a P/E ratio of 15.05, a P/E/G ratio of 2.27 and a beta of 0.45. The stock has a 50 day simple moving average of $290.20 and a two-hundred day simple moving average of $371.22. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on UNH shares. Oppenheimer decreased their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research note on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research note on Wednesday, May 14th. Raymond James Financial downgraded UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Finally, Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $355.77.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.